Phase 2
N=100
Efficacy and Safety of a Hospital Walking Program for Older Adults
Acute Disease
Bottom Line
View on ClinicalTrials.gov: NCT00715962 ↗Enrolled (actual)
100
Serious AEs
16.0%
Results posted
Mar 2016
Primary outcome: Primary: Falls — 0; 2 participants — p=<.05
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Behavioral intervention (Behavioral); Walking Intervention (Other); Friendly visits (Other)
- Age
- Older Adult · 65+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Falls |
0; 2 | <.05 sig |
| PRIMARY Amount of Time Spent Out of Bed as Measured by Wireless Accelerometers |
43.0; 44.7 | — |
| SECONDARY Life-Space Assessment Score |
52.5; 41.6 | <.05 sig |
Summary
Low mobility, defined as being limited to bed or chair, is common during acute hospitalization. This study will evaluate the impact and safety of a hospital walking program for older patients during acute general medical hospitalization. Participants who are 65 years of age or older, will be randomized to usual care (UC) or to a hospital walking program (WP), which includes twice daily walks with assistance, provision of necessary ambulatory devices, and a behavioral intervention strategy designed to encourage out of bed activity. Throughout hospitalization, the WP and UC veterans will were wireless monitors on the thigh and ankle that measure activity. The primary goal will be in increase the length of time veterans spend out of bed and to assure this out of bed activity is safe.
Eligibility Criteria
Inclusion Criteria
- Age greater or equal to 65 years;
- Admitted to the Birmingham VAMC for a medical condition
Exclusion Criteria
- Delirious based on positive Confusion Assessment Method (CAM);
- Mini-Cognitive Assessment score indicating dementia;
- Inability to ambulate 2 weeks prior to admission;
- Having a medical diagnosis deemed by the primary physician to be a contraindication to ambulation;
- patient with an imminently terminal illness; and
- Non-English speaking
Data sourced from ClinicalTrials.gov (NCT00715962). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.